Suchergebnisse - "Duan, Xiao-Tong"

PubPharm (5)

1

Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma : A phase II trial

enthalten in: Cell reports. Medicine | 2023

von Chen, S. | Duan, X. | Li, H. | +21

2

Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma : a multicentre, randomised, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von You, R. | Liu, Y. | Xie, Y. | +36

CommentIn: Lancet. 2023 Mar 18;401(10380):878-879. - PMID 36842441

3

Radiotherapy combined with PD-1/PD-L1 inhibitors in NSCLC brain metastases treatment : The mechanisms, advances, opportunities, and challenges

enthalten in: Cancer medicine | 2023

von Chen, Z. | Duan, X. | Qiao, S. | +1

4

Radiotherapy combined with PD‐1/ PD‐L1 inhibitors in NSCLC brain metastases treatment : The mechanisms, advances, opportunities, and challenges

enthalten in: Cancer Medicine | 2023

von Chen, Z. | Duan, X. | Qiao, S. | +1

5

Characteristics Analysis of the Surface Ozone Concentration of China in 2015

enthalten in: Huan jing ke xue= Huanjing kexue | 2017

von Duan, X. | Cao, N. | Wang, X. | +4

1
[1]